期刊文献+

HIF-1α和表达及意义Survivin在乳腺癌中的 被引量:6

The expressions and significance of HIF-1α and Survivin in breast carcinoma
原文传递
导出
摘要 目的探讨低氧诱导因子-1α(HIF-1α)和生存素(Survivin)在乳腺癌中的表达及意义。方法选择日照市人民医院2009年6月至2014年6月,应用免疫组化Ultra Sensitive^TM S-P法检测的乳腺浸润性导管癌(IDC)128例、乳腺导管原位癌(DCIS)89例、乳腺非典型导管增生(ADH)57例以及乳腺普通导管增生(UDH)60例,分析HIF-1α和Survivin的阳性表达差异及其与临床病理因素的关系。结果HIF-1α的表达在IDC与DCIS组(Х^2=13.442)、ADH组(Х^2=22.272)以及UDH组(Х^2=52.789)比较,差异有统计学意义,DCIS与UDH组比较(Х^2=8.144,P=0.004)差异同样有统计学意义,DCIS与ADH比较差异无统计学意义(Х^2=2.188,P=0.139);Survivin的表达在IDC组(Х^2=70.540,P=0.000)、DCIS组(Х^2=51.967,P=0.000)、ADH(Х^2=42.829,P=0.000)与UDH组相比较,差异有统计学意义(P〈0.0083);IDC与DCIS(Х^2=1.330,P:0.249)、IDC与ADH(Х^2=1.484,P=0.223)比较,Survivin的表达差异均无统计学意义(P〉0.0083)。在乳腺癌中,HIF-1α与Survivin的表达与组织学分级、淋巴结、远处转移及肿瘤分期呈正相关(P〈0.05),而与患者年龄、肿瘤大小无关(P〉0.05)。HIF-1α和Survivin的表达正相关(P=0.018,95%CI:0.0376-0.3839),但一致性不理想(k=0.211)。结论HIF-1α、Survivin高表达与乳腺癌发生、侵袭及转移行为有关,HIF-1α与Survivin联合检测有望作为乳腺癌发生发展、复发转移及预后的指标。 Objective To study the expression and significance of Hypoxia inducible factor 1α(HIF-1α ) and Survivin in breast carcinoma. Methods Immunhistochemical Ultra SensitiveTM S-P method was employed to detect the expression of HIF-1α and Survivin in 128 cases invasive ductal carcinoma (IDC),89 cases of ductal carcinoma in situ (DCIS),57 cases of atypical ductal hyperplasia (ADH),and 60 cases of usual duct hyperplasia lesions (UDH).The multiple biological parameters including the cancer grade and stage were compared with and investigate the associations of HIF-1αand Survivin expressions in breast carcinoma. Results There were significant differences in the positive expression rates of HIF-1α between IDC and DCIS tissne(-=13.442),IDC and ADH(za=22.272),IDC and UDH(Х^2=52.789).The same with DCIS and UDH(Х^2=8.144,P=0.004).However,there were no significant differences of HIF-1α expression rates between DCIS and ADH(Х^2=2.188,P=0.139).At the same time,There were significant differenees(P〈0.008 3) in the positive expression rates of Survivin between IDC and UDH(Х^2=70.540,P=0.000),DCIS and UDH0(Х^2=51.967,P=0.000),ADH and UDH(Х^2=42.829,P=0.000).There were no significant differences of Survivin expression rates between IDC and DCIS(Х^2=1.330,P=0.249),IDC and ADH0(E=1.484,P=0.223).There was positive correlation in over-expressions of HIF-1α and Survivin with histological grade, lymph node metastasis,distant metastasis and stage of IDC tumor, and the expressions of the two proteins were not related with age and tumor size (P〉0.05). There was poor correlation between HIF-1α and Survivin (P=0.018, 95%CI: 0.037 6-0.383 9). Conclusion The over-expression of HIF-1α and Survivin might be important biological markers for invasion ,lymph node metastasis and distant metastasis of IDC.The combined detection of HIF-1α and Survivin may be as the predictors of development and recurrence and prognosis of breat carcinoma.
出处 《中国临床实用医学》 2016年第1期20-23,共4页 China Clinical Practical Medicine
基金 山东省医药卫生科技发展计划项目课题(2014WS0282,2014WSA11003) 济宁医学院科研计划重点项目(JY2013KJ051) 日照市应用技术研究与开发计划项目(2014SZSH002)
关键词 乳腺癌 低氧诱导因子 生存素 免疫组织化学 预后 Breast carcinoma Hypoxia inducible factor 1α Survivin Immunohistochemistry Prognosis
  • 相关文献

参考文献17

  • 1Rundqvist H,Johnson RS.Tumour oxygenation: implications for breast cancer prognosis[J].J Intern Med,2013,274(2): 105-112. DOI: 10.11 11/ joim.12091.
  • 2Kaira K,Nakagawa K,Ohde Y,et al.Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non-small cell lung cancer[J].Int J Surg Pathol,2012,20(3):223-232. DOI: 10.1177/1066896911429296.
  • 3Kelly RJ,Lopez-Chavez A,Citrin D,et al.Impacting tumor cellfate by targeting the inhibitor of apoptosis protein survivin[J].Mol Cancer,2011,10:35. DOI:10.1186/1476-4598-10-35.
  • 4Wang G,Qin Y,Zhang J,et al.Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer[J].Int J Mol Sei,2014,15(6):9546-9565. DOI: 10.3390/ijms 15069546.
  • 5Lakhani SR, Ellis IO, Schnitt SJ, et al.WHO classification of tumours of the breast[M]. Lyon, France:lARC Press,2012:1-97.
  • 6Edge SB,Compton CC.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol,2010,17(6):1471-1474. DOI: 10.1245/s10434-010- 0985-4.
  • 7International Union against Cancer (UICC): TNM classification of malignant tumors 7th ed. Sobin LH,Gospodarowicz MK, Wittekind Ch. Eds. Wiley-Blackwell. Oxford. 2009.
  • 8王刚平,梁云爱,张作峰,张红,梁粉花.CD105标记微血管密度及HIF-1α在乳腺癌及癌前病变中的表达及意义[J].中华临床医师杂志(电子版),2013,7(16):30-34. 被引量:13
  • 9俸瑞发,柏璐,郑默然,秦琴,黄玥,张珊,刘晓萌.乳腺癌组织HIF—1α、Ki67及VEGF表达的临床意义[J].中华内分泌外科杂志,2013,7(2):93-97. 被引量:12
  • 10Janke K,Brockmeier U,Kuhlmann K,ET AL.Factor inhibiting HIF- 1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)[J].J Cell Sci,2013,126(12):2629-2640. DOI:10.1242/jcs.117564.

二级参考文献37

  • 1刘敏,翟晓辉,王莹,金木兰,郭晓娟,李杰.乳腺肿瘤缺氧诱导因子-1α的表达与BOLD-MRI成像的关系研究[J].中华临床医师杂志(电子版),2012,6(20):65-68. 被引量:4
  • 2钱晓芹,杨光.血管密度、血管内皮生长因子在乳腺癌中的表达及超声影像相关性研究进展[J].临床超声医学杂志,2004,6(6):366-368. 被引量:6
  • 3孙文洲,于丽波,张清媛.HIF-1α蛋白在乳腺癌发生、发展不同阶段的表达及意义[J].第四军医大学学报,2007,28(2):163-165. 被引量:12
  • 4Bachtiary B, Schindl M, Ptitter R, et al. Overexpression of hypoxi- a-inducible factor 1 ct indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer[J]. Clin Cancer Res,2003,9(6) :2234-2240.
  • 5Schoppmannl SF, Fenzl A, Schindl M, et al. Hypoxia inducible factor-lc correlates with VEGF-C expression and lymphangiogene-sis in breast cancer [ J ]. Breast cancer Res Treat,2006,99 (2) : 135-141.
  • 6Yamamoto Y, Ibsuki M, Okumura Y, et al. Hypoxia-inducible factor 1 alpha is closely linked to an aggressive phenotype in breast cancer [ J ]. Breast Cancer Res Treat,2008,110 (3) :465-475.
  • 7Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia inducible factor-hx in common human cancers and their metastass[J]. Cancer Res,1999,59(22) :5830-5835.
  • 8Isner JM, Asahara T. Angiogenesis and vasculogenesis as thera- peutic strategies for postnatal neovascularization [ J]. J Clin Invest, 1999,103(9) :1231-1236.
  • 9Yeo E J, Chun YS, Cho YS, et al. YC-1 : apotential anticancer drug Targeting hypoxia-inducible factor 1 [J].J Natl Cancer Inst ,2003, 95 (7) :516-525.
  • 10Koh MY,Spivak-Kroizman TR,Powis G.HIF-lalpha and cancer thera- py[J].Recent Results Cancer Res, 2010,180:15-34.

共引文献38

同被引文献61

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部